European Medicines Agency - News and Events - Xigris (drotrecogin alfa (activated)) to be withdrawn due to lack of efficacy: "Xigris (drotrecogin alfa (activated)) to be withdrawn due to lack of efficacy
PROWESS-SHOCK study shows no gain in 28-day survival of septic shock patients"
'via Blog this'
No comments:
Post a Comment
Note: only a member of this blog may post a comment.